	Consolidative therapy for PSMA-avid lesions after 3 cycles of apalutamide plus androgen deprivation in metastatic hormone-sensitive prostate cancer: A prospective phase 2 single-arm trial. Eur J Nucl Med Mol Imaging Pan J, Wang B, Zhu B, Gan H, Hu X, Liu X, Li X, Wu J, Wang H, Zhang Q, Liu C, Song S, Ma X, Ye D, Zhu Y. PMID: 42252348 [PubMed - as supplied by publisher]
	Spatial Transcriptomics Open a New Era of Pan-Cancer Analysis. Cancer Invest Sheng Y, Yang Y, Zhang R, Li M, Ge Q. PMID: 42252208 [PubMed - as supplied by publisher]
	Educational inequalities in all and site-specific cancer mortality: Mediation analysis of health behaviors from a 7-year cohort study in Japan. J Epidemiol Kiuchi S, Matsuyama Y, Ojima T, Saito M, Kondo K, Osaka K, Aida J. PMID: 42252186 [PubMed - as supplied by publisher]
	Efficacy of targeted hepatocellular carcinoma therapy using modified response evaluation criteria in solid tumors and alpha-fetoprotein: A single center retrospective exploratory study. Ann Hepatobiliary Pancreat Surg Lin K, Ye L, Jiang Z, Li R, Shi H, Yu Y. PMID: 42252118 [PubMed - as supplied by publisher]
	Advances in early-stage lung cancer patients: from preanalytics to molecular analysis. Crit Rev Oncol Hematol Pepe F, Gristina V, Russo TDB, L'imperio V, Mangogna A, Russo G, Scimone C, Borea R, Cozzolino D, Russo A, Troncone G, Rolfo C, Malapelle U. PMID: 42252070 [PubMed - as supplied by publisher]
	The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions. Crit Rev Oncol Hematol Lenjisa JL, Kasirzadeh S, Safaroghli-Azar A, Mekonnen LB. PMID: 42252069 [PubMed - as supplied by publisher]
	Bridging the Gap Between Infection and Detection: Biological, Clinical, and Health System Contributors to Diagnostic Delay in HPV-Associated Cervical Cancer. Crit Rev Oncol Hematol Buhay BR, Chin JD, Han RY, Wakefield MR, Fang Y. PMID: 42252068 [PubMed - as supplied by publisher]
	Radiation therapy in adolescents and young adults (AYA): contemporary evidence on utilization, outcomes, late toxicities, and second malignant neoplasms - A comprehensive systematic review and synthesis. Radiother Oncol Simbirova A, Thomas E, Hessel F, Valentini C, Crijns APG, Dasu A, Grégoire V, Hoyer M, Sala NJ, Langendijk JA, Maerten P, Orlandi E, Rylander H, Pardo GS, Tanguy R, Jentsch C, Troost EGC, KAYAC+ consortium, funded by Pianoforte . PMID: 42251999 [PubMed - as supplied by publisher]
	Continuous erector spinae plane block for robotic-assisted thoracic surgery in lung cancer: a dual-center retrospective propensity-score weighted cohort study. Braz J Anesthesiol Arraes M, Amaral S, Silveira SQ, da Silva LM, Nersessian RSF, Bezerra FJL, Neto MS, Nunes CM, Lima HO, Bellicieri FN, Mizubuti GB, Lombardi R. PMID: 42251994 [PubMed - as supplied by publisher]
	Gasdermin proteins as pyroptosis-based biomarkers in ovarian cancer: Diagnostic and prognostic utility. Clin Chim Acta Alruwaili MM, Alenazi MS, Mostafa HM, Rehman ZU, Alshammari MK, Alam A, Ali A, Khan A. PMID: 42251925 [PubMed - as supplied by publisher]
	IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms. J Thorac Oncol Beasley MB, Yatabe Y, Papotti M, Cooper WA, Derks JL, Fernandez-Cuesta L, Kasajima A, Lantuejoul S, Pelosi G, Rekhtman N, Roden AC, Jan M Speel E, Travis WD. PMID: 42251892 [PubMed - as supplied by publisher]
	Integrating chest CT-derived skeletal muscle index with SARC-F for sarcopenia screening in patients with lung cancer. Lung Cancer Weng H, Li Y, Yang L, Chen S, Li J, Ruan L, Zeng Q, Zhang G, Zeng Y. PMID: 42251829 [PubMed - as supplied by publisher]
	Cancer-associated and non-neoplastic fibrosis: Comparative mechanisms and emerging antifibrotic strategies. Biomed Pharmacother Riccò B, Grisendi G, Monaco AL, Giuggioli D, Clini E, Dominici M. PMID: 42251804 [PubMed - as supplied by publisher]
	Avoidance of immune mediated tumor rejection by cancer cells. Adv Biol Regul Pekarsky Y, Croce CM. PMID: 42251797 [PubMed - as supplied by publisher]
	Integrative single-cell and spatial transcriptomics analysis reveals a baicalein-responsive 10-gene signature for non-small cell lung cancer. Transl Oncol Wu D, Liu C, Zhan L, Liang M, Li Q, Lian Q. PMID: 42251782 [PubMed - as supplied by publisher]
	Stimuli-responsive nanogels as intelligent nanocarriers for tumor microenvironment-triggered anticancer drug delivery. Discov Nano Wal A, Bukke SPN, Vidiyala N, Jamil S, Sharma KK, Khan A, Dutta A, Sunkishala P, Gasmi A. PMID: 42251617 [PubMed]
	Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer. Discov Oncol Feng W, He W. PMID: 42251607 [PubMed - as supplied by publisher]
	Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study. Ann Saudi Med Akagunduz F, Güren AK, Kocaaslan E, Paçac, Tunç MA, Demirel A, A, Erel P, Çelebi A, I, Coban E, Sar, Bayo, Köstek O, Demircan NC. PMID: 42251515 [PubMed - in process]
	Levels of Physical Activity and Sedentary Lifestyle in Patients With Hematological Cancer Treated With Monoclonal Antibodies as a Monotherapy or Combination Therapy (Immunochemotherapy): A Comparative Study With Healthy Individuals. Med Sci Monit Pude, Dybko J, Malicka I. PMID: 42251486 [PubMed - in process]
	TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer. Acta Clin Belg Van Damme M, Elzo-Kraemer X, Deman A, Vulsteke C, Dendooven A, De Waele L. PMID: 42251484 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1941174

Page 1 of 97059



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy